Financial News
All News about Natera Inc
From Natera, Inc.
Via Business Wire
The Analyst Landscape: 8 Takes On Natera
December 29, 2023
Via Benzinga
The Latest Analyst Ratings for Natera
December 12, 2023
Via Benzinga
Analyst Expectations for Natera's Future
November 09, 2023
Via Benzinga
Analyst Ratings for Natera
October 16, 2023
Via Benzinga
From Natera, Inc.
Via Business Wire
Natera Announces Real-World Data Collaboration with Merck
November 14, 2023
From Natera, Inc.
Via Business Wire
Disney, Twilio, TransDigm, Marathon Digital And Other Big Stocks Moving Higher On Thursday
November 09, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
Natera Reports Third Quarter 2023 Financial Results
November 08, 2023
From Natera, Inc.
Via Business Wire
Natera Announces Randomized, Phase III TREAT ctDNA Trial in Early-Stage Breast Cancer
November 08, 2023
From Natera, Inc.
Via Business Wire
Natera to Participate in November Investor Conferences
November 07, 2023
From Natera, Inc.
Via Business Wire
Natera to Report its Third Quarter 2023 Results on November 8
October 20, 2023
From Natera, Inc.
Via Business Wire
From Natera, Inc.
Via Business Wire
Natera Submits First PMA Module to the FDA for Signatera™
October 02, 2023
From Natera, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
September 28, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.